Ardelyx, Inc. (ARDX)
3.73
-0.03
(-0.80%)
USD |
NASDAQ |
Sep 02, 14:33
Ardelyx Cash from Operations (Annual) : -42.48M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -42.48M |
| December 31, 2024 | -44.81M |
| December 31, 2023 | -89.72M |
| December 31, 2022 | -70.04M |
| December 31, 2021 | -152.55M |
| December 31, 2020 | -81.44M |
| December 31, 2019 | -76.48M |
| Date | Value |
|---|---|
| December 31, 2018 | -70.27M |
| December 31, 2017 | -65.19M |
| December 31, 2016 | -92.53M |
| December 31, 2015 | -71.84M |
| December 31, 2014 | 13.40M |
| December 31, 2013 | 1.811M |
| December 31, 2012 | 21.98M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| REGENXBIO, Inc. | -123.96M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |
| Savara, Inc. | -101.04M |